“…Assays that have shown promise include colony survival assays (Brock et al, 1995;West et al, 1998), chromosomal aberration frequency (Neubauer et al, 1997(Neubauer et al, , 2002Distel et al, 2006), comet assay (Brammer et al, 2001), DNA damage and repair based on pulsedfield gel electrophoresis (PFGE) (Wurm et al, 1994;McKay and Kefford, 1995;Zhou et al, 1998), micronucleus assay (Nachtrab et al, 1998;Sprung et al, 2005), telomere length (McIlrath et al, 2001;Sprung et al, 2008), SNP analysis (Severin et al, 2001;Gurska et al, 2007;Wilding et al, 2007;Alsner et al, 2008), DNA end binding complexes (Ismail et al, 2004) and transcriptional profiling (Rieger et al, 2004;Svensson et al, 2006;Sprung et al, in preparation). Thus, many potential endpoints exist, most of which have been partially successful in identifying clinical RS.…”